Retirement Systems of Alabama’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-34,775
Closed -$2.85M 925
2021
Q2
$2.85M Buy
34,775
+17
+0% +$1.41K 0.01% 884
2021
Q1
$3.31M Buy
34,758
+1,159
+3% +$110K 0.01% 871
2020
Q4
$2.08M Sell
33,599
-50
-0.1% -$2.85K 0.01% 901
2020
Q3
$2M Buy
33,649
+76
+0.2% +$5.19K 0.01% 852
2020
Q2
$2.34M Sell
33,573
-1,005
-3% -$63.7K 0.01% 820
2020
Q1
$1.57M Sell
34,578
-2,081
-6% -$118K 0.01% 845
2019
Q4
$2.38M Sell
36,659
-2,954
-7% -$197K 0.01% 868
2019
Q3
$2.46M Sell
39,613
-1,255
-3% -$78.8K 0.01% 850
2019
Q2
$2.91M Sell
40,868
-1,796
-4% -$132K 0.01% 828
2019
Q1
$3.35M Sell
42,664
-1,507
-3% -$114K 0.02% 803
2018
Q4
$3.74M Buy
+44,171
New +$4.71M 0.02% 732

Other funds holding LGND

Retirement Systems of Alabama's LGND Position: Q3 2021 in Review

Retirement Systems of Alabama sold out of Ligand Pharmaceuticals (LGND) in Q3 2021, closing a stake of 34,775 shares — an estimated $2.85M sold.

Retirement Systems of Alabama first reported a position in LGND in Q4 2018 and held it in 11 quarters. The position peaked at $3.74M in Q4 2018. 207 funds tracked by Wall St. Rank hold LGND as of Q3 2021.

  • Retirement Systems of Alabama reported no remaining Ligand Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Retirement Systems of Alabama sold 34,775 Ligand Pharmaceuticals shares in Q3 2021, an estimated $2.85M.
  • Retirement Systems of Alabama first reported a position in Ligand Pharmaceuticals in Q4 2018 and held it in 11 quarters.
  • Retirement Systems of Alabama's Ligand Pharmaceuticals position peaked at $3.74M in Q4 2018.
  • 207 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2021.

Based on Retirement Systems of Alabama's 13F filing for Q3 2021, filed 3 Nov 2021.